Newton One Investments LLC - SAGE THERAPEUTICS INC ownership

SAGE THERAPEUTICS INC's ticker is SAGE and the CUSIP is 78667J108. A total of 203 filers reported holding SAGE THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is 0.23 and the average weighting 0.1%.

Quarter-by-quarter ownership
Newton One Investments LLC ownership history of SAGE THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$4,116
-56.2%
2000.0%0.00%
-60.0%
Q2 2023$9,404
+12.1%
2000.0%0.01%0.0%
Q1 2023$8,392
+10.0%
2000.0%0.01%0.0%
Q4 2022$7,628
-4.6%
2000.0%0.01%
-16.7%
Q3 2022$8,000
+33.3%
2000.0%0.01%
+50.0%
Q2 2022$6,000
-14.3%
2000.0%0.00%
-20.0%
Q1 2022$7,000
-22.2%
2000.0%0.01%
-16.7%
Q4 2021$9,0000.0%2000.0%0.01%
-14.3%
Q3 2021$9,000
-18.2%
2000.0%0.01%
-22.2%
Q2 2021$11,000
-26.7%
2000.0%0.01%
-30.8%
Q1 2021$15,000
-11.8%
2000.0%0.01%
-23.5%
Q4 2020$17,0002000.02%
Other shareholders
SAGE THERAPEUTICS INC shareholders Q3 2022
NameSharesValueWeighting ↓
Third Rock Ventures, LLC 9,773,073$490,901,00052.36%
Ghost Tree Capital, LLC 240,000$12,056,0002.17%
EcoR1 Capital, LLC 112,455$5,649,0001.88%
New Leaf Venture Partners, L.L.C. 43,770$2,199,0001.49%
AlpInvest Partners B.V. 12,195$613,0001.15%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 595,443$29,909,0000.97%
APEX CAPITAL, LLC 190,000$9,544,0000.69%
OAK RIDGE INVESTMENTS LLC 385,770$19,377,0000.43%
Lombard Odier Asset Management (USA) Corp 92,089$4,626,0000.37%
SPHERA FUNDS MANAGEMENT LTD. 65,724$3,301,0000.34%
View complete list of SAGE THERAPEUTICS INC shareholders